Vitamina D3

Quick links to important sections

Vitamina D3

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitamina D3

What is Vitamina D3? The Identity of Colecalciferol

Property Description
Active Ingredient Colecalciferol (Cholecalciferol)
Form Oral drops (oil solution), soft capsules, or tablets
Pharmacological Class Fat-soluble vitamin, Antirachitic agent
General Role Calcium metabolism regulator
Origin Synthetic for pharmaceuticals, or Natural (skin synthesis)

What Type of Substance is Colecalciferol (Vitamina D3)?

Vitamina D3 is an essential micronutrient identified chemically as Colecalciferol, a fat-soluble vitamin and a structural seco-steroid prohormone. It is functionally categorized as an Antirachitic agent and its role in human health is clinically recognized.

Colecalciferol functions as a prohormone, meaning it is biologically inactive until converted in the body to the active steroid hormone, calcitriol. Pharmaceutical preparations are typically manufactured synthetically. The D3 form is generally recognized as the physiologically more effective agent compared to Vitamina D2 (Ergocalciferol) for maintaining consistent human vitamin status over time.


Composition and Pharmaceutical Form

The active core of the medicine is the pure substance Colecalciferol. Due to its lipophilic nature, Vitamina D3 is frequently supplied as a single-ingredient product dissolved in an oily vehicle, such as medium-chain triglycerides, to ensure stability and enhanced bioavailability upon oral administration.

Common dosage forms include oral drops (the oil solution), soft capsules, or tablets. The liquid oil formulation is often necessary for specific patient groups, such as infants and children, where a precise, adjustable liquid dose is required.


What is the General Role of Vitamina D3 in the Body?

The general role of Vitamina D3 is to serve as a crucial Calcium metabolism regulator, ensuring the body effectively handles the minerals necessary for structural health. It primarily enhances the intestinal absorption of both calcium and phosphate derived from the diet.

This fundamental regulatory action is the basis of its therapeutic purpose: to prevent or correct deficiency (Hypovitaminosis D). By helping to maintain adequate concentrations of calcium and phosphate in circulation, Vitamina D3 directly supports the process of bone mineralization, which is vital for the long-term strength and skeletal integrity of bones and teeth.

Regulatory References

  1. Cholecalciferol (Vitamin D3): MedlinePlus Drug Information
  2. Vitamin D Fact Sheet for Consumers | NIH ODS

What side effects are possible with Vitamina D3?

The safety profile of Colecalciferol (Vitamina D3) is primarily focused on the risks associated with its effect as a calcium regulator, with adverse reactions documented according to their frequency and the physiological system affected.

Documented Adverse Reactions

The most clinically significant effects are related to mineral homeostasis. Hypercalcaemia (elevated blood calcium) and Hypercalciuria (elevated urine calcium) are classified as Uncommon adverse reactions, occurring in 0.1% to 1% of individuals in regulatory studies. Rare effects (less than 0.1%) involve the Skin and Subcutaneous Disorders, including Pruritus (itching), Rash, and Urticaria (hives). Gastrointestinal effects such as Constipation, Flatulence, and Abdominal pain are also officially listed as Rare.

Serious Safety Considerations

The most serious adverse effects are a direct consequence of severe overexposure, known as Hypervitaminosis D. This toxic state is characterized by severe, sustained hypercalcaemia, which is documented in regulatory labeling as potentially leading to serious outcomes. These include Renal Calcinosis (calcium deposits in the kidney), Nephrolithiasis (kidney stones), and Cardiac Arrhythmia (irregular heartbeat). Severe Hypersensitivity Reactions such as Angiooedema have also been reported.

Population-Specific Safety Constraints

Official documents indicate specific constraints for certain populations. Colecalciferol is contraindicated in patients with pre-existing high calcium levels (Hypercalcaemia, Hypercalciuria) or certain kidney conditions (Nephrolithiasis). Caution is advised for individuals with Renal Insufficiency or conditions like Sarcoidosis due to altered metabolism, often requiring specific monitoring of calcium and kidney function. Furthermore, long-term treatment mandates routine monitoring of both serum and urinary calcium levels.

Overdose and Emergency Response

Overdose and When to Seek Help

Vitamina D3 overdose is officially classified as Hypervitaminosis D, with the critical consequence being Hypercalcaemia (an excess of calcium in the blood). This condition is potentially life-threatening and requires immediate action.

Documented Manifestations Severe Outcomes and Complications
Nausea, vomiting, anorexia, fatigue, and headache. Kidney failure (Nephrocalcinosis) and reduced renal function.
Excessive thirst (Polydipsia), frequent urination (Polyuria), and mental disturbances (confusion). Cardiac arrhythmias and soft tissue calcification.

Required Emergency Action

Urgent medical attention must be sought immediately upon the suspicion or diagnosis of Hypercalcaemia. The required first action is the immediate discontinuation of all Colecalciferol and supplemental calcium intake. Due to the lack of a specific antidote, management is symptomatic and supportive. Procedures focus on lowering calcium levels through aggressive rehydration (e.g., intravenous saline), a low-calcium diet, and the administration of agents like diuretics or corticosteroids as needed. Close clinical monitoring of serum and urinary calcium levels, renal function, and cardiac activity (EKG) is required. The elderly and those with pre-existing renal impairment are noted as populations requiring careful monitoring.

Therapeutic Uses of Vitamina D3

What Vitamina D3 treats: Main Uses and Benefits

Vitamina D3 is applied in addressing Hypovitaminosis D (deficiency/insufficiency) and is commonly used in the symptomatic management of conditions where skeletal integrity becomes affected. This includes supporting the maintenance of Bone Mineral Density (BMD) in conditions like Osteoporosis, and may be part of symptomatic management for bone softening disorders such as Rickets and Osteomalacia.

The therapy is relevant for easing symptomatic patterns of deficiency, notably symptoms related to physical discomfort like chronic bone pain and non-specific muscle aches, as well as functional impairments like muscle weakness. Colecalciferol may assist with managing symptoms related to muscle strength and mobility, which contributes to easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable.

Vitamina D3 is commonly used in situations involving certain distressing symptoms, such as those involving breastfed infants, individuals with severely limited sun exposure, and patients with underlying gastrointestinal diseases that cause malabsorption. Its application is considered relevant in contexts involving heightened systemic burden, providing supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Symptomatic Musculoskeletal Discomfort Colecalciferol plays a role in managing the groups of symptoms that may become intense or disruptive, helping to address the noticeable physiological strain caused by weakness and bone aches linked to deficiency.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Colecalciferol (Vitamina D3)

Official regulatory information defines strict population eligibility based on metabolic status, kidney function, and life stage. Colecalciferol is contraindicated (must not be used) in patients with Hypercalcaemia (high blood calcium), Hypercalciuria, or pre-existing D-Hypervitaminosis (excess vitamin D levels). Use is also prohibited for individuals with severe renal impairment, Nephrolithiasis (kidney stones), or known hypersensitivity to the product.

Restrictions and Conditional Use

Population Group Regulatory Status
Infants and Children Permitted for prophylaxis (prevention), but most tablet forms are not recommended for children under 12 years of age.
Pregnancy (High Dose) Not recommended at high therapeutic doses, though standard daily doses are generally permitted.
Moderate Renal Impairment Requires caution and close monitoring of calcium and phosphate levels.
Sarcoidosis Requires caution due to increased risk of hypercalcaemia.
Breastfeeding Women Permitted at recommended standard doses for maternal deficiency.

Eligibility criteria permit general use in adults and the elderly for deficiency treatment. These regulations govern who is allowed to take the medicine under standard labeled conditions.

What should I know about interactions with other medicines?

The official interaction profile for Colecalciferol (Vitamina D3) details specific constraints for co-administration with other medicines and products based on pharmacokinetic and pharmacodynamic effects. Co-administration with other Vitamin D metabolites or analogues (e.g., Calcitriol) is formally advised against due to the documented risk of hypercalcemia.

Pharmacokinetic interactions include the risk of reduced Colecalciferol effect when used alongside certain hepatic enzyme inducers, such as anticonvulsants (e.g., Phenytoin) and Rifampicin, due to enhanced metabolic inactivation. Furthermore, the absorption of Colecalciferol is decreased by co-administration with bile acid sequestrants (e.g., Cholestyramine) and fat malabsorption agents, requiring mandatory timing separation of doses.

Pharmacodynamic interactions involve Thiazide Diuretics, which are documented to increase the hypercalcemic effect of Colecalciferol. This increase in calcium can, in turn, increase the toxicity of cardiac glycosides (e.g., Digoxin). Use with aluminum- or magnesium-containing antacids is documented to increase the risk of specific mineral toxicities (aluminum or hypermagnesemia, respectively). This risk is noted to be particularly elevated in patients with impaired renal function.

Mechanism of Action

Vitamina D3 is a regulator of mineral homeostasis, influencing the reabsorption and excretion of calcium and reducing calcium excretion. Its biological mechanism involves the activation of the Vitamin D Receptor (VDR), a nuclear receptor that, upon binding with its active form, calcitriol, forms a heterodimer with the Retinoid X Receptor (RXR). This complex targets specific DNA sequences, known as Vitamin D Response Elements (VDREs), to modulate gene expression. Specifically, this cascade is crucial for the efficient and complete absorption of dietary calcium and phosphate in the intestine. The active form exhibits high direct binding affinity for the VDR, which results in the modulation of systemic calcium and phosphate levels.

Dosage and Administration Information

How to Use Vitamina D3 (Colecalciferol)

The administration of Colecalciferol is oral and follows specific protocols designed to correct or prevent deficiency. Dosing is generally separated into two phases: a loading dose phase for short-term correction, and a lower maintenance dose for long-term use. Typical maintenance dosing for adults ranges from 800 to 2,000 IU daily, while initial treatment regimens may employ higher, less frequent doses, such as 50,000 IU once weekly for a period of several weeks.

Colecalciferol is available as tablets, soft capsules, or an oral solution (drops). Due to its fat-soluble nature, the medicine is generally recommended to be taken with the main meal of the day to enhance absorption.

Administration Specifics

Population / Form Specific Administration Guidance
Pediatric Use Infants often require the oral drop formulation for precise daily dosing (e.g., 400 IU daily).
Severe Renal Impairment The product is generally not recommended for patients with severe renal impairment (eGFR < 35 mL/min) due to limited data and altered metabolism.
Combination Tablets If the medicine is part of a combination product (e.g., with bisphosphonates), highly specific rules apply: the tablet must be swallowed whole with plain water at least 30 minutes before the first food of the day, and the patient must remain upright for 30 minutes after dosing.
Missed Dose If a regular dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped. Doubling the dose to compensate is not recommended.

Recent Clinical Evidence

Research evidence / Overview of studies for Vitamina D3

Research has explored Colecalciferol’s (Vitamina D3) role as a calcium metabolism regulator. This overview describes the research that has been conducted and what study outcomes were monitored across three key areas, without offering any clinical direction or personal recommendations.


Research Evidence for Correcting Vitamin D Deficiency

Studies rely heavily on Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. These monitored Colecalciferol in association with the key biomarker, 25-hydroxyvitamin D [25(OH)D] concentration, in populations characterized by low baseline levels. Reported measurements of the biomarker status are documented with high consistency across research.

Uncertainty exists because the precise level defining "deficiency" is not uniformly agreed upon across all global health guidelines, and differences in laboratory testing can introduce variability into reported findings.


Research Evidence for Bone Health and Skeletal Integrity

The evidence base involves long-term RCTs. Many of these studies evaluated Colecalciferol alongside supplemental calcium, monitoring structural endpoints like changes in Bone Mineral Density (BMD) and the incidence of fractures in populations such as older adults and individuals with osteoporosis. Scientific reviews note that inconsistent findings have been described regarding structural outcomes when Colecalciferol is evaluated as a single substance (without calcium co-administration).


Research Evidence for Symptomatic Musculoskeletal Comfort

Research explored patient-reported experiences related to physical discomfort that may be associated with Vitamin D deficiency. Studies examined functional measures, such as muscle strength, and pain scales. Changes in outcomes appears to be more pronounced in patient subgroups with severe deficiency at baseline, but reported patterns show high variability. Evidence for this area is generally considered moderate.


Evidence in Special Patient Populations

Research has also been evaluated in subgroups including infants and children (for Rickets outcomes), older adults prone to falls, and patients with underlying gastrointestinal diseases that limit absorption.


Long-Term Study Durations and Follow-up

Studies monitoring structural outcomes required long-term observational periods, ranging up to four years. However, long-term effects are not fully established regarding sustained outcomes beyond the skeletal system. Research exploring extra-skeletal outcomes has yielded mixed findings in large-scale RCTs, and methodological limitations remain concerning short follow-up for rare events.

Frequently Asked Questions (FAQ)

Common questions about Vitamina D3 (FAQ)


Q: What is Vitamina D3 used for?

A: Vitamina D3 (cholecalciferol) is generally recognized as important for calcium absorption in the gut and maintaining adequate serum calcium and phosphate concentrations, which are necessary for bone mineralization. It supports skeletal health.


Q: Can I get enough Vitamin D3 from sunlight?

A: Sunlight exposure is a primary source, as the skin produces Vitamin D3 when exposed to UVB radiation. However, factors like geography, season, time of day, sunscreen use, and skin pigmentation can limit production. Dietary intake and supplements may be needed to maintain adequate levels, especially in certain populations.


Q: What are common side effects of Vitamina D3?

A: At typically recommended supplemental intakes, Vitamin D3 is generally well-tolerated. Side effects are usually associated with taking excessively high doses over a prolonged period, which may lead to high calcium levels (hypercalcemia) and symptoms like nausea, vomiting, or excessive thirst. Consult a healthcare professional if you have concerns.


Q: Should I take Vitamina D3 with food?

A: Vitamin D3 is a fat-soluble vitamin, and it may be better absorbed when taken with a meal or snack that contains some fat. This is a general recommendation to support absorption, but specific dosing instructions should come from your doctor or pharmacist.

How should Vitamina D3 be stored and disposed of?

Storage and Handling Requirements

Vitamina D3 (colecalciferol) must be stored strictly according to regulatory mandates to maintain its stability. The product should be stored at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F).

Protection from environmental factors is mandatory: the medicine must be protected from light and moisture and must not be frozen. It is required to keep the product in its original container and the container must be kept tightly closed.

For safety, all formulations of this medicine must be kept out of the reach of children.


Official Disposal Protocol

Expired or unused Vitamin D3 must be disposed of safely. The official guidance is to utilize a medicine take-back program where available. If a program is not available, the product should be mixed with an undesirable substance (such as dirt) and placed in a sealed container for household trash disposal. It must not be flushed down a toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vitamina D3 found in:

A-Z Index: